Delaware Valley Biopharmaceutical Hub for Enterprises,<br />
Local Innovation, Commercialization and Security
Delaware Valley Biopharmaceutical Hub for Enterprises,
Local Innovation, Commercialization and Security
dblhelics border

Leading the Way

The Delaware Valley BiopharmaceuticaL Hub for Enterprises, Local Innovation, Commercialization and Security (DBLHELICS) TechHub will ensure U.S. leadership in biopharma manufacturing by developing domestic talent, attracting capital to the Greater Philadelphia Region, and by setting an example for regions throughout the U.S.

Biopharma Researcher

Investing in our future

Biopharmaceuticals are revolutionizing medicine. Manufacturing these treatments is challenging as they rely on living cells for their production, but they help save, sustain, and improve lives. Biopharmaceutical production requires advanced manufacturing and technologies to assure the identity, purity, and potency of the final product. These medicines treat and prevent some of the most significant and debilitating diseases including autoimmune disorders, cancers, and viral infections.

The Delaware Valley BiopharmaceuticaL Hub for Enterprises, Local Innovation, Commercialization and Security (DBLHELICS) is a consortium representing the intersection of government priorities, existing regional assets, resources and capabilities, and an industry with projected significant global growth.

The potential of the region for global competitiveness

The U.S. biopharma industry is poised for growth. The global biopharma market is strong with significant capital investment and employment growth; however, despite the market strength, the U.S. is experiencing a trade deficit. The U.S. must leverage its leadership in biopharmaceutical discovery and make robust investments in domestic biomanufacturing infrastructure and good, stateside jobs.

%

Global Biopharma Market Annual Growth Rate

The global biopharma market was about $343 billion in 2021 and is expected to reach $719 billion by 2030 with an annual growth rate of 7.8%.

Strong Capital Investment

The biopharma industry was #1 among R&D-intensive industries for capital investment in 2018.

Opportunity to grow domestic supply chains

The U.S. trade balance in biopharmaceuticals went from neutral in 2000 to an $85 billion deficit by 2020.

Supports Over 4 Million Jobs Across the Country

The overall biopharma industry has a workforce of 900,000 total direct jobs supporting a total of 4.4 million jobs including supply chains.

SOURCE: Emergen: 2021 Press Release | Walsh and Walsh: Biopharmaceutical Benchmarks 2022 | Pharmaceutical Research & Manufacturers of America (2022) | Ezell (2021). Going, Going, Gone? To Stay Competitive in Biopharma, America Must Learn From Its Semiconductor Mistakes.

DBLHELICS Regional Partnerships

DBLHELICS will coordinate and leverage existing regional partnerships across DE/NJ/PA borders, and create a diverse workforce of individuals with well-paying jobs. It will leverage the region’s venture community, capital, and industry best practices to move products from lab-to-market and will create a globally competitive region within 10 years that:

Leveraging Resources

Leveraging existing biopharmaceutical (biopharma) innovation assets, resources, and capacity

Promoting Workforce Development

Investing in new job opportunities aligned with future biopharma manufacturing trends and needs

Supporting National Competitiveness

Directly support U.S. economic competitiveness, national security, and public health
dblhelics partner map

DBLHELICS includes partners from the Philadelphia-Camden-Wilmington the adjacent Dover, DE, and Salisbury, MD-DE MSAs: a region hosting diverse individuals, opportunities, and companies, representative of the U.S. at large. Emphasizing workforce development initiatives, DBLHELICS’ outcomes will be scalable to rural, suburban, and urban locations across the U.S., maximizing this TechHub’s national impact.

Discover the Power of DBLHELICS

Learn how local resources, capabilities and partnerships are poised for remarkable biopharmaceutical global expansion. Connect with us today!

 

Delaware Valley Biopharmaceutical Hub for Enterprises, Local Innovation, Commercialization and Security
Copyright © 2023 The Delaware Valley BiopharmaceuticaL Hub for Enterprises, Local Innovation, Commercialization and Security – All Rights Reserved.

ADDRESS

STAR Campus
590 Avenue 1743
Newark, DE 19713 U.S.A.

GENERAL INQUIRIES:

Share This